Antitumor Activity of Orally Available Cyclic Peptide LUNA18 through Direct Pan-RAS Inhibition across Diverse RAS Genetic Alterations
Year: 2026
Type: article
Source: Molecular Cancer Therapeutics
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7171837795
FWCI:
Cites:
Cited by:
Related to:
